Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27
about
Olean-12-eno[2,3-c] [1,2,5]oxadiazol-28-oic acid (OEOA) induces G1 cell cycle arrest and differentiation in human leukemia cell linesTranscriptome analysis of tetraploid cells identifies cyclin D2 as a facilitator of adaptation to genome doubling in the presence of p53Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765.PKC-β as a therapeutic target in CLL: PKC inhibitor AEB071 demonstrates preclinical activity in CLL.The impact of CDK inhibition in human malignancies associated with pronounced defects in apoptosis: advantages of multi-targeting small molecules.Phospho-specific flow cytometry identifies aberrant signaling in indolent B-cell lymphomaMethylation of INK4 and CIP/KIP families of cyclin-dependent kinase inhibitor in chronic lymphocytic leukaemia in Chinese patientsTLR-9 and IL-15 Synergy Promotes the In Vitro Clonal Expansion of Chronic Lymphocytic Leukemia B Cells.Mammalian target of rapamycin (mTOR) inhibition in chronic lymphocytic B-cell leukemia: a new therapeutic option.Cell cycle phase distribution analysis in chronic lymphocytic leukaemia: a significant number of cells reside in early G1-phaseTranslational repression of cyclin D3 by a stable G-quadruplex in its 5' UTR: implications for cell cycle regulationToll-like receptor agonists in the treatment of chronic lymphocytic leukemia.Immunoglobulin gene translocations in chronic lymphocytic leukemia: A report of 35 patients and review of the literature.Mammalian target of rapamycin (mTOR) pathway signalling in lymphomas.CTLA-4 affects expression of key cell cycle regulators of G0/G1 phase in neoplastic lymphocytes from patients with chronic lymphocytic leukaemia.Massive and parallel expression profiling using microarrayed single-cell sequencing.The role, mechanism and potentially therapeutic application of microRNA-29 family in acute myeloid leukemiaThe role of toll-like receptors in chronic B-cell malignancies.Identification of cyclin D3 as a direct target of E2A using DamID.Critical role for D-type cyclins in cellular transformation induced by E6/E7 of human papillomavirus type 16 and E6/E7/ErbB-2 cooperation.Protein expression analysis of chromosome 12 candidate genes in chronic lymphocytic leukemia (CLL).Cyclin D1 is essential for neoplastic transformation induced by both E6/E7 and E6/E7/ErbB-2 cooperation in normal cells.Metformin inhibits cell cycle progression of B-cell chronic lymphocytic leukemia cells.Interphase Molecular Cytogenetic Detection Rates of Chronic Lymphocytic Leukemia-Specific Aberrations Are Higher in Cultivated Cells Than in Blood or Bone Marrow Smears.Sorafenib induces cell death in chronic lymphocytic leukemia by translational downregulation of Mcl-1.Expression of cyclin E in resting and activated B-chronic lymphocytic leukaemia cells: cyclin E/cdk2 as a potential therapeutic target.Cell cycle dependency of caspase activation in Fas-induced apoptosis in leukemia cells.Chronic Lymphocytic Leukemia B-Cell Normal Cellular Counterpart: Clues From a Functional Perspective.Cytokinesis arrest and multiple centrosomes in B cell chronic lymphocytic leukaemia.Chromosome Preparation for Chronic Lymphoid Malignancies.Expression and regulation of CacyBP/SIP in chronic lymphocytic leukemia cell balances of cell proliferation with apoptosis.Cyclin D2 is overexpressed in proliferation centers of chronic lymphocytic leukemia/small lymphocytic lymphoma.The Akt signaling pathway determines the different proliferative capacity of chronic lymphocytic leukemia B-cells from patients with progressive and stable disease.High Mda-7 expression promotes malignant cell survival and p38 MAP kinase activation in chronic lymphocytic leukemia
P2860
Q28488148-4C1AD28D-1E05-4623-83F7-47D3982FBD3AQ28552677-B1873B0B-617F-4300-87C5-002C18E76FBFQ34026194-B939A432-2FAA-4296-99B8-7DBADF00BB92Q34106863-798C89F3-5D76-437F-AE7B-84EECF29E961Q34195072-3816EA1E-87B3-4E1E-AD4C-DC0BAC589862Q34448586-569E07A0-8368-4DC4-BF4B-90F89CA07159Q35770277-CCDFD7AC-E8D3-42CF-85DF-88B71CDBC9F0Q35861964-35CB47AF-E745-4288-B7B2-89C4FDD69392Q35994885-DEBB86D8-A841-4573-9815-97ABD0C4812DQ36017262-6065D97A-C54D-4897-8633-DD93B8139E7BQ36552839-2E829D4E-26DE-48D1-BFF6-2D42718EC426Q36635059-79FDCAF2-BDF3-45B8-AC4C-36CC71173A26Q36824956-864C1660-C9B6-4A75-A93C-D846251B35D5Q37074284-47BDF5F4-553D-49F5-B0A3-3E28C1A266D5Q37143869-EB1F5FA8-35CB-4A62-A489-30730FFF8F38Q37345329-B25CA908-B287-4B9B-BD72-0DFDFFA51782Q37379386-2B253C70-390F-40E3-A6CA-0A81C013B01CQ37578343-B8BD1476-66AF-40D4-A862-96C788023B34Q39998534-8D6944AF-DA8A-4DC3-8844-F3049C71F634Q40134961-6A135EE2-CBE6-4200-B6E7-0BFB56AEAD03Q40420609-E9077069-D382-4DA1-BCDB-AEA393BEEA4EQ40539899-6506A222-4F55-4A5C-8FED-1A113DFA34EFQ42272463-00EDF169-DF95-49A9-9354-291126223158Q42383604-0B2F09D8-6D66-43CC-AFAF-4DBD0BA9AEECQ42752579-CDB1CC8A-DD2C-46D6-936C-07AE0532AC67Q47836904-221BFB07-2A36-48B9-97D6-A4B1837F628BQ51983520-C438F45C-BE10-4267-B492-983D95A91B43Q52579132-6C7640F0-C481-425D-B73C-1F305855E28EQ52727954-68C5564D-9F84-4574-92CB-9E5DAD44EBF3Q52817321-91E182E9-F475-4CD1-AC07-CFD8C348CBEFQ52900621-80C0FE1E-79B9-4E12-AD10-2C75ABF60FECQ53230105-F862B585-5E01-4733-95E5-5B9C941832FFQ53595110-9AAA049A-7B04-4816-B566-A82A99B561B5Q58041746-8C8A7E95-DA58-4F5E-AB85-2D0EFBA2BCE2
P2860
Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Cell cycle progression of chro ...... k) 4 and the cdk inhibitor p27
@ast
Cell cycle progression of chro ...... k) 4 and the cdk inhibitor p27
@en
Cell cycle progression of chro ...... k) 4 and the cdk inhibitor p27
@en-gb
Cell cycle progression of chro ...... k) 4 and the cdk inhibitor p27
@nl
type
label
Cell cycle progression of chro ...... k) 4 and the cdk inhibitor p27
@ast
Cell cycle progression of chro ...... k) 4 and the cdk inhibitor p27
@en
Cell cycle progression of chro ...... k) 4 and the cdk inhibitor p27
@en-gb
Cell cycle progression of chro ...... k) 4 and the cdk inhibitor p27
@nl
prefLabel
Cell cycle progression of chro ...... k) 4 and the cdk inhibitor p27
@ast
Cell cycle progression of chro ...... k) 4 and the cdk inhibitor p27
@en
Cell cycle progression of chro ...... k) 4 and the cdk inhibitor p27
@en-gb
Cell cycle progression of chro ...... k) 4 and the cdk inhibitor p27
@nl
P2093
P3181
P356
P1433
P1476
Cell cycle progression of chro ...... k) 4 and the cdk inhibitor p27
@en
P2093
P2888
P304
P3181
P356
10.1038/SJ.LEU.2402389
P407
P577
2002-03-01T00:00:00Z
P5875
P6179
1033665604